Safety of long-acting beta-agonists in stable COPD: a systematic review

Some studies have suggested that use of long-acting beta(2)-agonists (LABAs) leads to an increased risk for adverse events in patients with stable COPD. The purpose of this review was to assess the safety, and secondarily the efficacy of LABAs. The authors conducted a systematic review with metaanal...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chest 2008-05, Vol.133 (5), p.1079-1087
Hauptverfasser:	Rodrigo, Gustavo J, Nannini, Luís J, Rodríguez-Roisin, Roberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Agonists - therapeutic use Bronchoconstriction - drug effects Delayed-Action Preparations - therapeutic use Disease Progression Humans Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - physiopathology Secondary Prevention Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!